Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yi-Ran Si"'
Autor:
Yi‐Kun Kang, Yi‐Ran Si, Jie Ju, Zhu‐Qing Jia, Nan‐Lin Hu, Hao Dong, Xue Wang, Jian Yue, Pei‐Di Jiang, Zhao‐Liang Li, Yun‐Yun Zhang, Yan Wang, Bing‐He Xu, Peng Yuan
Publikováno v:
Cancer Medicine, Vol 12, Iss 5, Pp 5323-5333 (2023)
Abstract Background Early prediction of treatment response is crucial for the optimal treatment of advanced breast cancer. We aimed to explore whether monitoring early changes in plasma human epidermal growth factor receptor 2 (HER2) levels using dig
Externí odkaz:
https://doaj.org/article/9851eead41c14b3f967b0cfd6750234a
The Effects of Endocrine Therapies on Lipid Profiles in Chinese Young Women With Early Breast Cancer
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
This study aimed to evaluate and compare the effects of various endocrine therapies on lipid profiles in young patients with breast cancer. A retrospective, single-center study was performed to investigate the effects of tamoxifen (TAM), tamoxifen pl
Externí odkaz:
https://doaj.org/article/d565b46f58e94209ae692e62c04d97b9
Impact of coronavirus disease 2019 on the clinical diagnosis and treatment of breast cancer in China
Autor:
Yi-Ran Si, Feng Du, Nan-Lin Hu, Xue Wang, Jian Yue, Pei-Di Jiang, Bing-He Xu, Peng Yuan, Li-Shao Guo, the Breast Cancer Group, Chinese Association for Clinical Oncologist
Publikováno v:
Chinese Medical Journal, Vol 134, Iss 5, Pp 590-592 (2021)
Externí odkaz:
https://doaj.org/article/4b51ac0e3d9443a5ad98bb53ba3e7b24
Autor:
Jie Ju, Feng Du, Song-Lin Gao, Yi-Ran Si, Nan-Lin Hu, Dong-Xu Liu, Xue Wang, Jian Yue, Fang-Chao Zheng, Yi-Kun Kang, Zi-Xuan Yang, Fei Ma, Bing-He Xu, Peng Yuan
Publikováno v:
Breast Cancer Research and Treatment. 194:221-230
Hormone receptor-positive and human epidermal growth factor receptor 2-positive (HR+/HER2+ breast cancer comprise approximately 5-10% of all invasive breast cancers. However, the lack of knowledge regarding the complexity of tumor heterogeneity in HR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d231a192c8a5095a5d461b8ab8938f1
https://doi.org/10.1007/s10549-022-06629-w
https://doi.org/10.1007/s10549-022-06629-w
Autor:
Yi‐Kun Kang, Yi‐Ran Si, Jie Ju, Zhu‐Qing Jia, Nan‐Lin Hu, Hao Dong, Xue Wang, Jian Yue, Pei‐Di Jiang, Zhao‐Liang Li, Yun‐Yun Zhang, Yan Wang, Bing‐He Xu, Peng Yuan
Publikováno v:
Cancer medicineREFERENCES.
Early prediction of treatment response is crucial for the optimal treatment of advanced breast cancer. We aimed to explore whether monitoring early changes in plasma human epidermal growth factor receptor 2 (HER2) levels using digital PCR (dPCR) coul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25dee14bebd96d5d50ece788378c747d
https://pubmed.ncbi.nlm.nih.gov/36281495
https://pubmed.ncbi.nlm.nih.gov/36281495
Publikováno v:
Gland Surg
BACKGROUND: Our study aimed to compare the efficacy and safety of anthracycline plus taxane (AT)-based neoadjuvant chemotherapy (NAC) with or without cyclophosphamide in the treatment of breast cancer. METHODS: We searched PubMed, Embase, Web of Scie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eef6873107916d9b30d2ce25f6c12f37
https://doi.org/10.21037/gs-20-593
https://doi.org/10.21037/gs-20-593